Widely used arthritis pill protects against skin cancer, study suggests

A widely used arthritis drug reduces the incidence of non-melanoma skin cancers -- the most common cancers in humans -- according to a new study. The COX-2 inhibitor celecoxib (Celebrex), which is approved for the treatment of arthritis and acute pain, led to a 62 percent reduction in non-melanoma skin cancers. In the future, a combination of medications that include sunscreens and COX inhibitors or other protective therapies may be used to decrease the incidence of skin cancer.

Read the whole article on Science Daily

More from Science Daily